Geneva Pharma Network

Independent consultant in the field of Antibody Enginneering

Rate this item
(1 Vote)

• Provide as a service the design of humanization of mouse / rat antibodies using a modernized version of the traditional CDR grafting technique.
• Provide as a service project plan for antibody projects from discovery to preclinical development and oversee if necessary the progression of the project.
• Due diligence and evaluation of antibody technologies.
• Provide expert advice on broad antibody engineering aspects; especially choice of isotype, affinity maturation, effector function and FcRn binding.

Additional Info

  • Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Contact at GPN: Olivier Leger